Navigation Links
MiMedx Addresses FDA Untitled Letter And Reiterates 2013 And 2014 Guidance
Date:9/4/2013

u of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 170,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

Safe Harbor Statement
This press release includes statements that look forward in time or that express management's beliefs, expectations or hopes.  Such statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements include, but are not limited to the resolution of the FDA's concerns and the timing thereof, the Company's belief that the FDA's conclusion is based on a misunderstanding of the Company's micronization process, whether the Company will be able to continue to sell its injectable product or refocus its resources and the Company's achievement of its revenue goals for 2013 and 2014. These statements are based on current information and belief, and are not guarantees of future performance.  Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include that the issues raised in the FDA letter are not timely or favorably resolved, that the Company is unable to sell its injectable product or to refocus its resources, that the Company may not meet its revenue goals for 2013 and 2014, and the risk factors detailed from time to time in the Company's periodic Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended December 31, 2012. By making these forward-looking statements, the Company does not undertake to update them in any manner except as may be required by the Company's di
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MiMedx Group, Inc. Announces Release Date for 2013 Second Quarter Results
2. MiMedx Announces 2012 Results
3. MiMedx Group to Present at the 6th Annual OneMedForum
4. MiMedx Group to Present at the Stifel Nicolaus 2012 Healthcare Conference
5. CorePharma Addresses Violations in FDA Warning Letter
6. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
7. CVS Caremark CEO Addresses Economic Club of Pittsburgh on Reinventing Pharmacy for Better Health
8. Issue Brief Addresses Stage 2 Meaningful Use Patient Education and Engagement Initiatives
9. Generex Addresses Recent Trading Volume in Shares of its Common Stock
10. ACEP Commends Congress For Passing Legislation That Addresses Drug Shortages As Well As "Bath Salts"
11. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... it has completed the sale to Galderma of all ... or held by Valeant for $1.4 billion in cash, ... which recently completed its acquisition of Galderma. ... our products to a company that is firmly committed ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 /PRNewswire/ ... three-quarters of surveyed infectious disease (ID) specialists are ... Medicines Company,s Orbactiv (oritavancin) for use as OPAT, ... to prescribe these agents to their hospital inpatients. ... percent) of OPAT patients are initiated on OPAT ...
(Date:7/10/2014)... 2014 CVS Caremark Corporation (NYSE: CVS ... a quarterly dividend of $0.275 (27.5 cents) per share on ... 1, 2014, to holders of record on July 21, 2014. ... is dedicated to helping people on their path to better ... the United States . Through the company,s more than ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 17 The Department of,Justice announced today that ... CEO,Roundtable on Cancer (CRC) to develop and publicize ... cancer treatments. The Department said,the language is not ... to help,increase efficiency in contract negotiations, potentially reducing ...
... (OTC Bulletin Board: BSTC), a biopharmaceutical company,developing first ... of a U.S. Phase IIb clinical trial in ... its partner Auxlium,Pharmaceuticals, Inc., "We are very ... this trial,into a Phase IIb based on our ...
Cached Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease 3
(Date:7/11/2014)... Anterior Cruciate Ligament (ACL) happens all too frequently, however ... Orthopaedic Society for Sports Medicine,s (AOSSM) Annual Meeting suggests ... may minimize the chance of a future ACL tear. ... factors such as, age, activity level and type of ... said lead author, Christopher C. Kaeding, MD of the ...
(Date:7/11/2014)... NY (PRWEB) July 11, 2014 Wild by ... is proud to announce they are opening a fifth store ... Wild by Nature offers one of the largest selections of ... people diagnosed with celiac disease, these stores have become a ... gluten-free diet. , Gluten sensitivity, and gluten intolerance, is a ...
(Date:7/11/2014)... BellasDress, the experienced dressmaker in the ... suppliers when it comes to beach wedding dresses ... of beach wedding outfits in its online shop. Included ... outfits. , BellasDress has been considered as one ... to the company’s senior spokesman, BellasDress provides superb special ...
(Date:7/11/2014)... Growing old was thought of as a fate that was ... was shown that many of the “myths” people associate with ... out, the elderly can still live quite as fruitfully as their ... time in the world, older people also need to live a ... the twilight of their lives. This is why Guy Coalter, the ...
(Date:7/11/2014)... July 11, 2014 Plasma resource reserves ... products industry. Although the closure of 16 plasma collection ... to domestic blood products market, the total plasma volume ... on year and total lot release volume declined by ... stock consumption, insufficient utilization of new plasma stations and ...
Breaking Medicine News(10 mins):Health News:Wild by Nature Opens New Location 2Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4
... of your New Year resolutions, The Alliance for Aging Research// ... of both physical as well as mental exercise to stay ... nonprofit Alliance for Aging Research said, "There is a lot ... prevent or lessen the cognitive decline that often comes with ...
... habit of offering fruit juices and sugar added beverages ... better to avoid sugary drinks in cups with sippers ... the sipper attached. The American Academy of Pediatric Dentistry (AAPD) ... cups do help to avoid liquids from spilling over from ...
... for patients in ICU by adhering to simple techniques ... infections. // ICUs can become thoroughly aseptic by ensuring ... and catheters. A detailed report was made by experts ... the report are published in New England Journal of ...
... parents to encourage their children to put away the video ... AMA Vice President, Dr Choong-Siew Yong, said today. ... soccer balls and tennis racquets are a great way to ... ,“Swimming or horse-riding lessons, bicycle outings, backyard cricket, or just ...
... junta, left for Singapore to receive treatment for an intestinal ... who has led Myanmar's junta - the self-styled State Peace ... the country Sunday on a special flight arranged by businessman ... ,An informed source in the government said Than Shwe, ailing ...
... the calories a person consumes can prevent, or at least ... suggests// that body composition – whether a person is ... risks. ,In other words, how the body ... than how many or how few calories are consumed—a finding ...
Cached Medicine News:Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2Health News:Keep Kids Active in the Holidays 2Health News:Body Composition Is Key Player in Controlling Cancer Risks 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features: Eppendorf ...
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
... a fully adjustable, air-displacement pipette with a ... latest member of the Pipetman family, sharing ... and precision. We also added a number ... customers. Eight models cover the full range ...
Medicine Products: